1. Role: Department Vice-Chair. Scope: Department. Date: 2021.
Jamie L. Miller, Pharm.D., BCPS, BCPPS, FPPAG
Professor
Pharmacy Clinical & Admin Sci
Phone (405) 271-6878 x47296
Office O'Donoghue Research Bldg., 1122 NE 13th St., Ste. 4417, OKC 73117
Email jamie-miller@ouhsc.edu
Publications & Presentations
- 26. Stephens K, Barker P, Bergeron E, Miller J L, Hagemann T M, Lewis T V, Neely S, Johnson P N. Comparison of Clinical Outcomes and Medication Use of Obese Versus Nonobese Children Admitted to the Pediatric Intensive Care Unit. Hospital pharmacy. 2021; 56 : 287-295
27. Harkin M, Miller J L, Lim S Y, Neely S, Walsh C, Johnson P N. "Reply: Conversion From Continuous Infusion Fentanyl to Hydromorphone in the Pediatric Intensive Care Unit". The Annals of pharmacotherapy. 2021
28. Miller J L, Stephens K, Johnson P N, Medina M. Teaching residents how to deliver active learning during didactic lectures. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2021; 78 : 944-948
29. Miller J L. Neonatal Disease. Hunan Science and Technology Press. 2021 : 585-598
30. Lim S Y, Miller J L, Henry E, Heltsley R, Woo S, Johnson P N. Analysis of fentanyl pharmacokinetics, and its sedative effects and tolerance in critically ill children. Pharmacotherapy. 2021; 41 : 359-369
Grants
- 1. Evaluation of caffeine dosing regimens and the impact of developmental pharmacokinetics in neonates with apnea of prematurity. Misc Non-Federal. Start Date: 2020. End Date: 2021.
2. Characterization of fentanyl metabolic and renal elimination pathways in children less than two years of age. Misc Non-Federal. Start Date: 2018. End Date: 2020.
3. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.
4. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.
5. Comparison of amikacin pharmacokinetics in neonates pre- and post- a dosing protocol change. Misc Non-Federal. Start Date: 2014. End Date: 2015.
Awards and Honors
- 1. Oklahoma Residency Research Conference. Oklahoma Research Excellence Award (Mentor). Date: 2023.
2. Oklahoma Residency Research Conference. Oklahoma Research Excellence Award (Mentor). Date: 2023.
3. Pediatric Pharmacy Association. Christensen Memorial Young Investigator Award Nominee (Resident Mentor). Date: 2022.
4. Oklahoma Residency Research Conference. Oklahoma Research Excellence Award (Mentor). Date: 2019.
5. University of Oklahoma College of Pharmacy; Department of Clinical and Administrative Sciences. Best Paper Award. Date: 2018.
Education
- 1. Degree: PharmD. Southwestern Oklahoma State University. Date: 2006.
2. Degree: BS. Trevecca Nazarene University. Date: 2002.